Study of Botulinum Toxin and Recovery of Hand Function After Stroke
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether injections of botulinum toxin (commonly
known as BOTOX®) into the affected hand of Stroke patients, while targeting the muscles
controlling the hand, will lead to improved use of the hand when compared to injections of
placebo (a substance that looks similar to the study drug but contains no active study
medication).
Phase:
Phase 3
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health
Collaborator:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA